Cardiol Therapeutics Inc. CRDL 주가 예측
Cardiol Therapeutics Inc.에 대한 AI 기반 가격 예측 및 분석 · 업데이트됨 5월 11, 2026
AI 90일 예측
매수
7일
30일
90일
AI 신뢰도: -45% 스피어만 상관관계
5월 11, 2026
CRDL의 정확한 목표 주가 보기
무료 계정을 만들어 4,000개 이상의 종목에 대한 AI 예측 잠금 해제
Google로 무료 가입✓ 무료 계정 · ✓ 30일 체험 · ✓ 언제든지 취소
가격 차트
차트 로드 중...
핵심 통계
시가총액
$147M
정보 Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc. (CRDL) Life Sciences 섹터에서 운영, 특히 Biological Products, (No Diagnostic Substances) 업종에서 활동합니다. .
We do not have any company description for Cardiol Therapeutics Inc. at the moment.
최신 뉴스
- Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
- Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
- Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
- 무료 가입하여 10개 기사 모두 읽기 →
Biological Products, (No Diagnostic Substances) 동종 기업
| 회사 | 티커 | AI 신호 | 시가총액 | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $185M | -x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $1M | -x |
| Arcellx, Inc. | ACLX | ██% | $6.73B | -x |
| Alpha Cognition Inc. | ACOG | ██% | $133M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13.2x |
| Adma Biologics, Inc. | ADMA | ██% | $1.90B | 11.5x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $2.21B | -x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1.8x |
| Agenus Inc | AGEN | ██% | $159M | 1379.8x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $3M | -x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $233M | -x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $40M | -x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $787M | -x |
| Alvotech | ALVO | ██% | $1.02B | -x |
| Amgen Inc | AMGN | ██% | $179.02B | 23.0x |
| Apogee Therapeutics, Inc. | APGE | ██% | $5.68B | -x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $48.40B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $305M | -x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $269M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0.2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $71M | 2.2x |
| Atyr Pharma Inc | ATYR | ██% | $93M | -x |
| Aura Biosciences, Inc. | AURA | ██% | $927M | -x |
| Autolus Therapeutics Plc | AUTL | ██% | $418M | -x |
| Anavex Life Sciences … | AVXL | ██% | $298M | -x |
| Bioatla, Inc. | BCAB | ██% | $8M | -x |
| Biocardia, Inc. | BCDA | ██% | $12M | -x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $8M | -x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.19B | -x |
| Black Diamond Therapeutics, … | BDTX | ██% | $171M | -x |
| Beam Therapeutics Inc. | BEAM | ██% | $3.32B | -x |
| Biogen Inc. | BIIB | ██% | $28.48B | 20.8x |
| Biontech Se | BNTX | ██% | $23.80B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $633M | -x |
| Candel Therapeutics, Inc. | CADL | ██% | $612M | -x |
| C4 Therapeutics, Inc. | CCCC | ██% | $325M | -x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1.0x |
| Creative Medical Technology … | CELZ | ██% | $9M | -x |
| Cero Therapeutics Holdings, … | CERO | ██% | $1M | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $894M | -x |
| Compugen Ltd | CGEN | ██% | $274M | 3.9x |
| Cg Oncology, Inc. | CGON | ██% | $6.13B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $108M | -x |
| Coherus Oncology, Inc. | CHRS | ██% | $262M | 1.6x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $3M | -x |
| Cellectis S.A. | CLLS | ██% | $387M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $330M | -x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $3M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1.5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $112M | -x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $147M | -x |
| Curis Inc | CRIS | ██% | $22M | -x |
| Crispr Therapeutics Ag | CRSP | ██% | $5.28B | -x |
| Champions Oncology, Inc. | CSBR | ██% | $84M | -x |
| Cel Sci Corp | CVM | ██% | $14M | -x |
| Dbv Technologies S.A. | DBVT | ██% | $1.17B | -x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $551M | -x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.11B | -x |
| Precision Biosciences Inc | DTIL | ██% | $198M | -x |
| Dyadic International Inc | DYAI | ██% | $28M | -x |
| Editas Medicine, Inc. | EDIT | ██% | $304M | -x |
| Eloxx Pharmaceuticals, Inc. | ELOX | ██% | $990K | -x |
| Elutia Inc. | ELUT | ██% | $47M | 0.9x |
| Engene Therapeutics Inc. | ENGN | ██% | $100M | -x |
| Entera Bio Ltd. | ENTX | ██% | $71M | -x |
| Viskase Holdings, Inc. | ENZN | ██% | $40M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $54M | -x |
| Evaxion A/S | EVAX | ██% | $36M | -x |
| Exelixis, Inc. | EXEL | ██% | $12.22B | 14.7x |
| Exozymes Inc. | EXOZ | ██% | $81M | -x |
| Fate Therapeutics Inc | FATE | ██% | $276M | -x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $530M | -x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $237M | -x |
| Finch Therapeutics Group, … | FNCH | ██% | $12M | 0.5x |
| Finch Therapeutics Group, … | FNCHQ | ██% | $13M | 0.5x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $163.11B | 17.7x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.64B | -x |
| Genenta Science S.P.A. | GNTA | ██% | $15M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Greenland Mines Ltd | GRML | ██% | $56M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $7.55B | 23.8x |
| Humacyte, Inc. | HUMA | ██% | $235M | -x |
| Immunitybio, Inc. | IBRX | ██% | $8.91B | -x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $272M | -x |
| Imagenebio, Inc. | IMA | ██% | $60M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.50B | -x |
| Immatics N.V. | IMTX | ██% | $1.52B | -x |
| Immunovant, Inc. | IMVT | ██% | $5.88B | -x |
| In8bio, Inc. | INAB | ██% | $16M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6.8x |
| Mink Therapeutics, Inc. | INKT | ██% | $55M | -x |
| Inmune Bio, Inc. | INMB | ██% | $38M | -x |
| Intensity Therapeutics, Inc. | INTS | ██% | $13M | -x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.59B | -x |
| Century Therapeutics, Inc. | IPSC | ██% | $413M | -x |
| Invivyd, Inc. | IVVD | ██% | $423M | -x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $26M | -x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $116M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.55B | -x |
| Krystal Biotech, Inc. | KRYS | ██% | $9.00B | 40.0x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $7.07B | -x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $565M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $333M | -x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $315M | -x |
| Atyr Pharma Inc | LIFE | ██% | $1.87B | -x |
| Liminatus Pharma, Inc. | LIMN | ██% | $9M | -x |
| Leonabio, Inc. | LONA | ██% | $94M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $426M | -x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.44B | -x |
| Mesoblast Ltd | MESO | ██% | $1.91B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $909M | -x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $53M | -x |
| Molecular Partners Ag | MOLN | ██% | $166M | -x |
| Moderna, Inc. | MRNA | ██% | $21.58B | -x |
| Neurocrine Biosciences Inc | NBIX | ██% | $15.32B | 22.9x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0.1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $329M | -x |
| Novavax Inc | NVAX | ██% | $1.66B | -x |
| Ocugen, Inc. | OCGN | ██% | $511M | -x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $27M | -x |
| Palisade Bio, Inc. | PALI | ██% | $302M | -x |
| Passage Bio, Inc. | PASG | ██% | $13M | -x |
| Vaxcyte, Inc. | PCVX | ██% | $7.65B | -x |
| Biomx Inc. | PHGE | ██% | $6M | -x |
| Pluri Inc. | PLUR | ██% | $35M | -x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $156M | -x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $8M | -x |
| Prime Medicine, Inc. | PRME | ██% | $580M | -x |
| Prokidney Corp. | PROK | ██% | $562M | -x |
| Pelthos Therapeutics Inc. | PTHS | ██% | $82M | -x |
| Qiagen N.V. | QGEN | ██% | $7.17B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $21M | -x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $324M | -x |
| Repligen Corp | RGEN | ██% | $6.96B | 135.5x |
| Regenxbio Inc. | RGNX | ██% | $537M | -x |
| Relay Therapeutics, Inc. | RLAY | ██% | $2.41B | -x |
| Revolution Medicines, Inc. | RVMD | ██% | $28.39B | -x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.76B | -x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $289M | 21.8x |
| Sana Biotechnology, Inc. | SANA | ██% | $936M | -x |
| Scilex Holding Co | SCLX | ██% | $55M | -x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $50M | -x |
| Solid Biosciences Inc. | SLDB | ██% | $715M | -x |
| Silexion Therapeutics Corp | SLXN | ██% | $2M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $31M | -x |
| Scholar Rock Holding … | SRRK | ██% | $5.76B | -x |
| Surrozen, Inc./De | SRZN | ██% | $333M | -x |
| Sutro Biopharma, Inc. | STRO | ██% | $667M | -x |
| Protara Therapeutics, Inc. | TARA | ██% | $282M | -x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.63B | -x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $83M | -x |
| Bio-Techne Corp | TECH | ██% | $7.57B | 69.1x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $543M | -x |
| Instil Bio, Inc. | TIL | ██% | $55M | -x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $247M | -x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3.5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.92B | -x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0.5x |
| Tevogen Bio Holdings … | TVGN | ██% | $31M | -x |
| Twist Bioscience Corp | TWST | ██% | $3.49B | -x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $378M | 42.0x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6.7x |
| Valneva Se | VALN | ██% | $615M | -x |
| Vericel Corp | VCEL | ██% | $1.71B | 79.5x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.47B | -x |
| Vivosim Labs, Inc. | VIVS | ██% | $4M | -x |
| Vor Biopharma Inc. | VOR | ██% | $918M | -x |
| Vaxart, Inc. | VXRT | ██% | $165M | 4.5x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $244M | -x |
| Windtree Therapeutics Inc … | WINT | ██% | $670K | -x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $418M | -x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $17M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $14M | -x |
| Zura Bio Ltd | ZURA | ██% | $454M | -x |
자주 묻는 질문
-
Cardiol Therapeutics Inc.은(는) 매수하기 좋은 주식인가요?
저희 AI는 Cardiol Therapeutics Inc.을(를) 매일 분석합니다. 위의 신호에서 최신 추천을 확인하세요. 투자 전 항상 직접 리서치를 수행하세요.
-
Cardiol Therapeutics Inc. 예측 정확도는 얼마나 되나요?
저희 AI는 이 종목에서 -45% 스피어만 상관관계를 달성하며, 매일 분석되는 4,000개 이상 종목에서 67% 이상의 평균 정확도를 보입니다.
-
예측은 얼마나 자주 업데이트되나요?
Cardiol Therapeutics Inc. 예측은 최신 시장 데이터와 AI 모델을 사용하여 매일 업데이트됩니다.
더 스마트하게 투자할 준비가 되셨나요?
AI 기반 주가 예측을 활용하는 수천 명의 투자자와 함께하세요
무료 가입✓ 무료 계정 · ✓ 4,000개 이상의 종목 · ✓ 매일 업데이트
Cardiol Therapeutics Inc.에 대한 심층 분석을 찾고 계신가요?
Intratio에서 기관 투자자 수준의 전체 분석 보기 →AI 예측은 과거 패턴에 기반하며 투자 결정의 유일한 근거가 되어서는 안 됩니다. 과거 실적이 미래 결과를 보장하지 않습니다. 항상 직접 리서치를 수행하세요.